Bionical Limited, a prominent player in the life sciences sector, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2015, the company has rapidly established itself as a leader in providing innovative solutions for the pharmaceutical and biotechnology industries. Bionical Limited specialises in a range of services, including clinical trial support, patient recruitment, and market access strategies, all designed to enhance the efficiency of drug development. Their unique approach combines advanced technology with deep industry expertise, ensuring tailored solutions that meet the specific needs of their clients. With a strong market position, Bionical Limited has achieved significant milestones, including partnerships with major pharmaceutical companies and recognition for their commitment to quality and innovation in the life sciences arena.
How does Bionical Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bionical Limited's score of 21 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Bionical Limited reported total carbon emissions of approximately 1,204,500,000 kg CO2e, with emissions primarily stemming from Scope 3, specifically business travel, which accounted for about 1,202,270,481 kg CO2e. The company also reported Scope 2 emissions of approximately 24,348 kg CO2e. Notably, Bionical Limited does not have data for Scope 1 emissions. Currently, Bionical Limited has not established any specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company has not disclosed any climate pledges or significant climate commitments, which places it in a context where further action may be necessary to align with industry standards for carbon reduction. As Bionical Limited is headquartered in Great Britain, it is essential for the organisation to consider implementing robust climate strategies to mitigate its substantial carbon footprint, particularly in the context of increasing regulatory and societal pressures for corporate sustainability.
Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Business Travel" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bionical Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.